Business
Firebrick Phase 3 Trial Closes with 500 Subjects
Firebrick Phase 3 Trial Closes with 500 Subjects
About this update from Firebrick Pharma Limited
[{"type":"text","content":"Firebrick Pharma Ltd has released a press release. View Attachment","length":233,"tagName":"div"}]